
CLINICAL STUDIES
LEMTRADA was studied in 2 two-year clinical trials, and many LEMTRADA-treated patients were invited to continue in an extension study for an additional four years, for a total of 6 years. Read about the results here.

HOW LEMTRADA IS GIVEN
LEMTRADA is given in two rounds of treatment, 12 months apart. Additional rounds of treatment may be given as needed.

SAFETY AND SIDE EFFECTS
There are potential infusion reactions and serious side effects when taking LEMTRADA. Get the facts here.

MONITORING PROGRAM
Monthly monitoring for 4 years after your last LEMTRADA infusion is an important part of your treatment plan. Find out why.